COMPARISON OF NOREPINEPHRINE AND DOBUTAMINE TO EPINEPHRINE FOR HEMODYNAMICS, LACTATE METABOLISM, AND GASTRIC TONOMETRIC VARIABLES IN SEPTICSHOCK - A PROSPECTIVE, RANDOMIZED STUDY
B. Levy et al., COMPARISON OF NOREPINEPHRINE AND DOBUTAMINE TO EPINEPHRINE FOR HEMODYNAMICS, LACTATE METABOLISM, AND GASTRIC TONOMETRIC VARIABLES IN SEPTICSHOCK - A PROSPECTIVE, RANDOMIZED STUDY, Intensive care medicine, 23(3), 1997, pp. 282-287
Objectives: To compare the effects of norepinephrine and dobutamine to
epinephrine on hemodynamics, lactate metabolism, and gastric tonometr
ic variables in hyperdynamic dopamine-resistant septic shock. Design:
A prospective, intervention, randomized clinical trial. Setting: Adult
medical/surgical intensive care unit in a university hospital. Patien
ts: 30 patients with a cardiac index (CI) > 3.51 . min(-1) . m(-2) and
a mean arterial pressure (MAP) less than or equal to 60 mmHg after vo
lume loading and dopamine 20 mu g/kg per min and either oliguria or hy
perlactatemia. Interventions: Patients were randomized to receive an i
nfusion of either norepinephrine-dobutamine or epinephrine titrated to
obtain an MAP greater than 80 mmHg with a stable or increased CI. Mea
surements and main results: Baseline measurements included: hemodynami
c and tonometric parameters, arterial and mixed venous gases, and lact
ate and pyruvate blood levels. These measurements were repeated after
1, 6, 12, and 24 h. All the patients fulfilled the therapeutic goals.
No statistical difference was found between epinephrine and norepineph
rine-dobutamine for systemic hemodynamic measurements. Considering met
abolic and tonometric measurements and compared to baseline values, af
ter 6 h, epinephrine infusion was associated with an increase in lacta
te levels (from 3.1 +/- 1.5 to 5.9 +/- 1.0 mmol/l; p < 0.01), while la
ctate levels decreased in the norepinephrine-dobutamine group (from 3.
1 +/- 1.5 to 2.7 +/- 1.0 mmol/l). The lactate/pyruvate ratio increased
in the epinephrine group (from 15.5 +/- 5.4 to 21 +/- 5.8; p < 0.01)
and did not change in the norepinephrine-dobutamine group (13.8 +/- 5
to 14 +/- 5.0). Gastric mucosal pH (pHi) decreased (from 7.29 +/- 0.11
to 7.16 +/- 0.07; p < 0.01) and the partial pressure of carbon dioxid
e (PCO2) gap (tonometer PCO2 - arterial PCO2) increased (from 10 +/- 2
.7 to 14 +/- 2.7 mmHg; p < 0.01) in the epinephrine group. In the nore
pinephrine-dobutamine group pHi (from 7.30 +/- 0.11 to 7.35 +/- 0.07)
and the PCO2 gap (from 10 +/- 3.0 to 4 +/- 2.0 mmHg) were normalized w
ithin 6 h (p, < 0.01). The decrease in pHi and the increase in the lac
tate/pyruvate ratio in the epinephrine group was transient, since it r
eturned to normal within 24 h. Conclusions: Considering the global hem
odynamic effects, epinephrine is as effective as norepinephrine-dobuta
mine. Nevertheless, gastric mucosal acidosis and global metabolic chan
ges observed in epinephrine-treated patients are consistent with a mar
kedly inadequate, although transient, splanchnic oxygen utilization. T
he metabolic and splanchnic effects of the combination of norepinephri
ne and dobutamine in hyperdynamic dopamine-resistant septic shock appe
ared to be more predictable and more appropriate to the current goals
of septic shock therapy than those of epinephrine alone.